Califf Deftly Defuses Sunscreen, DSHEA Probes In Confirmation Hearing

FDA commissioner nominee Robert Califf suggests adequate evidence is key to moving sunscreen TEAs through FDA’s evaluation process during his Senate confirmation hearing. He just as smoothly handled HELP Committee members’ questions about DSEHA and FDA rulemaking.

FDA commissioner nominee Robert Califf toes the line on evaluating sunscreen ingredients, telling Senate members the agency is open to moving quickly when sponsors provide the appropriate safety and efficacy evidence.

Califf emphasized evidence supporting sunscreen ingredient applications during his Nov. 17 confirmation hearing before the Senate Health, Education, Labor and Pensions Committee, a civil and at times jovial event absent...

More from United States

More from North America